Unlocking Growth in Europe DPP-4 Inhibitors Industry Market 2025-2033
The European DPP-4 Inhibitors market is experiencing steady growth, driven by rising type 2 diabetes prevalence. This in-depth analysis reveals market size, CAGR, key players (Eli Lilly, Novartis, Merck), leading drugs (Januvia, Onglyza), and regional trends, projecting market value to €2.21 billion by 2033.